Myanmar

The Food and Drug Administration (FDA) of Myanmar, operating under the Ministry of Health, serves as the primary regulatory authority responsible for the registration, licensing, and post-market surveillance of health products including pharmaceuticals, medical devices, diagnostics, and related health technologies. The principal governing legislation is the National Drug Law (1992) and its subsequent amendments, supplemented by the Food and Drug Administration Law (2018), which expanded the FDA's mandate and enforcement powers. All health products intended for sale or distribution in Myanmar must undergo a formal product registration process, which includes submission of a dossier, laboratory testing where applicable, and review by the relevant FDA technical committees before a registration certificate is granted.

Submission dossiers are generally expected to follow the Association of Southeast Asian Nations (ASEAN) Common Technical Dossier (ACTD) format, although alignment with the International Council for Harmonisation (ICH) Common Technical Document (CTD) is increasingly referenced for pharmaceutical submissions. Applicants must appoint a locally registered importer or authorized representative who holds a valid FDA business license and assumes regulatory responsibility within Myanmar. Key supporting documents typically include certificates of free sale or good manufacturing practice (GMP) certificates from the country of origin, product labeling compliant with Myanmar requirements, and, for medical devices, relevant international conformity assessments such as CE marking or ISO 13485 certification. Myanmar's regulatory framework has been gradually modernizing, with the FDA participating in the ASEAN Medical Device Directive (AMDD) harmonization initiative and efforts underway to streamline electronic submission processes, though implementation remains uneven and capacity constraints continue to affect review timelines.

Public sector procurement of health products in Myanmar is primarily coordinated through the Ministry of Health, with the Central Medical Stores Depot (CMSD) acting as the principal entity responsible for warehousing, distribution, and supply chain management of medicines, medical devices, and other health commodities across the public health system. National-level tenders are organized through established government procurement procedures subject to the Public Procurement Law (2017), with the Ministry of Planning and Finance providing overarching procurement governance. Budget allocations and procurement decisions are centralized at the union level, although township and state or region health departments play a role in needs assessment and distribution. Political instability since 2021 has significantly disrupted formal government procurement channels, reducing budget execution capacity and creating substantial supply chain fragmentation across the country.

Donor-funded and parallel procurement channels have become increasingly significant given the disruption to government systems. Key international organizations operating health commodity procurement in Myanmar include UNICEF, the Global Fund to Fight AIDS, Tuberculosis and Malaria, USAID through implementing partners, and the Three Millennium Development Goal Fund successor programs. These organizations often procure health products through their own international competitive tender processes, bypassing domestic FDA registration requirements in some emergency or programmatic contexts, or through UN interagency procurement mechanisms. The private sector represents a substantial share of health product distribution, with a fragmented network of private pharmacies, clinics, and hospitals served largely through licensed importers and wholesalers. Local manufacturing of pharmaceuticals exists but remains limited in scale and capacity; there are no strongly enforced local content preference policies at present, though the government has historically expressed interest in promoting domestic pharmaceutical production as a long-term strategic objective.